Transdiscal administration of high affinity anti-MMP inhibitors
US7429378B2 · kind B2 · utility
55Cited by
34References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 2003 |
| Grant date | Sep 30, 2008 |
| Priority date | — |
| Expiry date | Mar 22, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to injecting a high affinity antagonist of MMPs into a diseased intervertebral disc.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.